These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 1563484)
21. Perlecan inhibits smooth muscle cell adhesion to fibronectin: role of heparan sulfate. Lundmark K; Tran PK; Kinsella MG; Clowes AW; Wight TN; Hedin U J Cell Physiol; 2001 Jul; 188(1):67-74. PubMed ID: 11382923 [TBL] [Abstract][Full Text] [Related]
22. Modulation of proteoglycan synthesis by bovine vascular smooth muscle cells during cellular proliferation and treatment with heparin. Williams SP; Mason RM Arch Biochem Biophys; 1991 Jun; 287(2):386-96. PubMed ID: 1716868 [TBL] [Abstract][Full Text] [Related]
23. Differentially expressed patterns of glycosaminoglycan structure in heparan sulfate proteoglycans and free chains. Hovingh P; Piepkorn M; Linker A Eur J Biochem; 1993 Feb; 211(3):771-9. PubMed ID: 8436134 [TBL] [Abstract][Full Text] [Related]
24. Changes in heparan sulfate structure during transition from the proliferating to the non-dividing state of cultured arterial smooth muscle cells. Schmidt A; Buddecke E Eur J Cell Biol; 1990 Aug; 52(2):229-35. PubMed ID: 2081526 [TBL] [Abstract][Full Text] [Related]
25. Hemostatic properties and serum lipoprotein binding of a heparan sulfate proteoglycan from bovine aorta. Vijayagopal P; Srinivasan SR; Radhakrishnamurthy B; Berenson GS Biochim Biophys Acta; 1983 Jul; 758(1):70-83. PubMed ID: 6222769 [TBL] [Abstract][Full Text] [Related]
26. Metabolic pathways of heparan sulfate proteoglycans in a rat parathyroid cell line. Takeuchi Y; Yanagishita M; Hascall VC J Biol Chem; 1992 Jul; 267(21):14677-84. PubMed ID: 1634513 [TBL] [Abstract][Full Text] [Related]
27. Heterogeneity of cell-associated and secretory heparan sulphate proteoglycans produced by cultured human neuroblastoma cells. Hampson IN; Kumar S; Gallagher JT Biochim Biophys Acta; 1984 Sep; 801(2):306-13. PubMed ID: 6236854 [TBL] [Abstract][Full Text] [Related]
28. Biosynthesis of heparan sulfate proteoglycans of developing chick breast skeletal muscle in vitro. Noonan DM; Malemud DJ; Przybylski RJ Exp Cell Res; 1986 Oct; 166(2):327-39. PubMed ID: 2943601 [TBL] [Abstract][Full Text] [Related]
29. Heparin causes the accumulation of heparan sulfate in cultures of arterial smooth muscle cells. Potter-Perigo S; Wight TN Arch Biochem Biophys; 1996 Dec; 336(1):19-26. PubMed ID: 8951030 [TBL] [Abstract][Full Text] [Related]
30. Biosynthesis of heparan sulfate proteoglycan by human colon carcinoma cells and its localization at the cell surface. Iozzo RV J Cell Biol; 1984 Aug; 99(2):403-17. PubMed ID: 6235235 [TBL] [Abstract][Full Text] [Related]
31. Glypican (heparan sulfate proteoglycan) is palmitoylated, deglycanated and reglycanated during recycling in skin fibroblasts. Edgren G; Havsmark B; Jönsson M; Fransson LA Glycobiology; 1997 Feb; 7(1):103-12. PubMed ID: 9061369 [TBL] [Abstract][Full Text] [Related]
33. Induction of synthesis of a large heparan sulfate proteoglycan, perlecan, by thrombin in cultured human coronary smooth muscle cells. Yamamoto C; Wakata T; Fujiwara Y; Kaji T Biochim Biophys Acta; 2005 Feb; 1722(1):92-102. PubMed ID: 15716125 [TBL] [Abstract][Full Text] [Related]
34. Murine macrophage heparanase: inhibition and comparison with metastatic tumor cells. Savion N; Disatnik MH; Nevo Z J Cell Physiol; 1987 Jan; 130(1):77-84. PubMed ID: 3805131 [TBL] [Abstract][Full Text] [Related]
35. Effect of insulin and growth hormone on the synthesis of radiolabelled proteoglycans from cultured human arterial smooth-muscle cells. Thøgersen VB; Heickendorff L; Ledet T Eur J Endocrinol; 1996 Mar; 134(3):326-30. PubMed ID: 8616530 [TBL] [Abstract][Full Text] [Related]
36. Degradation of heparan sulfate in the subendothelial extracellular matrix by a readily released heparanase from human neutrophils. Possible role in invasion through basement membranes. Matzner Y; Bar-Ner M; Yahalom J; Ishai-Michaeli R; Fuks Z; Vlodavsky I J Clin Invest; 1985 Oct; 76(4):1306-13. PubMed ID: 2997275 [TBL] [Abstract][Full Text] [Related]
37. Investigation of plasma membrane-associated apolipoprotein E in primary macrophages. Deng J; Rudick V; Rudick M; Dory L J Lipid Res; 1997 Feb; 38(2):217-27. PubMed ID: 9162742 [TBL] [Abstract][Full Text] [Related]
38. Heparin sequences in the heparan sulfate chains of an endothelial cell proteoglycan. Nader HB; Dietrich CP; Buonassisi V; Colburn P Proc Natl Acad Sci U S A; 1987 Jun; 84(11):3565-9. PubMed ID: 2954157 [TBL] [Abstract][Full Text] [Related]
39. Tumor necrosis factor alpha-induced alteration of glycosaminoglycans in cultured vascular smooth-muscle cells. Kaji T; Hiraga S; Yamamoto C; Sakamoto M; Nakashima Y; Sueishi K; Koizumi F Biochim Biophys Acta; 1993 Mar; 1176(1-2):20-6. PubMed ID: 8452875 [TBL] [Abstract][Full Text] [Related]
40. Release of heparan sulfate proteoglycans from cultured aortic endothelial cells by thrombin. Shimada K; Ozawa T Thromb Res; 1985 Aug; 39(4):387-97. PubMed ID: 2931856 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]